Endothelin-1 as a target for therapeutic intervention in prostate cancer

Investigational New Drugs

Volumn 20, Issue 2, 2002, Pages 173-182

  Kopetz, E Scott ^a   Nelson, Joel B ^b   Carducci, Michael A ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Endothelin; Prostate cancer; Receptor antagonist

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN;

ADVANCED CANCER; ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER PAIN; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; HUMAN; METASTASIS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

APOPTOSIS; ENDOTHELIN-1; HALF-LIFE; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RECEPTORS, ENDOTHELIN; TISSUE DISTRIBUTION;

EID: 0036283452     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015630513908     Document Type: Review

References (104)

1. ECE-1: A membrane bound metalloprotease that catalyses the proteolytic activation of big endothelin-1
2. The endocrinology of vasoactive pep-tides: Synthesis to function
3. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: Differential effects of acute and chronic ETA receptor blockade
4. Regulation and Intracellular trafficking pathways of the endothelin receptors
5. The hydrolysis of endothelins by neutral endopeptidase
6. Endothelins: Circulating plasma levels and presence in other biologic fluids
7. Upregulation of endothelin 1 and its precursor by IL-1β, TNF-α, and TCG-β in the PC 3 human prostate cancer cell line
8. Endothelins in health and disease: An overview
9. The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells
10. Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology
11. Endothelin and the clinical and peripheral nervous systems: A decade of endothelin research
12. Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption
13. Endothelins in the urinary tract
14. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis
15. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
16. Subcellular mechanisms of endothelin action in vascular system
17. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src
18. Receptor-tyrosine-kinase and Gbg-mediated MAP kinase activation by a common signaling pathway
19. Role of trans-activation of the EGF receptor in signaling by G-protein coupled receptors
20. Molecular and functional characterization of the non-selective ET-B receptor in endothelial cells
21. Endothelin (ET)-3 stimulates cyclic guanosine 3′,5′-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomcrulus, and in cultured rat mesangial cells
22. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat
23. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells
24. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade
25. Termination of endothelin signaling: Role of nitric oxide
26. Release of endothelin from the porcine aorta: Inhibition by endothelin-derived nitric oxide
27. Autoregulation of endothelin-1 secretion by cultured human keratinocytes via the endothelin B receptor
28. Clearance of circulating endothelin-1 by ETB receptors in rats
29. Defining the role of endothelin in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies
30. Radioimmunoassay of endothelin
31. Endothelin in human plasma and culture medium or aortic endothelial cells-detection and characterization with radioimmune assay using monoclonal antibody
32. Endothelin-1 in the human prostate: Tissues levels, source of production and isometric tension studies
33. Endothelin-1 production and agonist activities in cultured prostate-derived cells: Implications for regulation of endothelin bioactivity in prostatic hyperplasia
34. Gene expression and autoradiographic localization of endothelin-1 and its receptors A and B in different zones of the normal prostate
35. Localization of endothelin receptors in the human prostate
36. Endothelin-1 production and decreased endothelin-B receptor expression in advanced prostate cancer
37. Endotheline-1 enhances vascular permeability in the rat heart through the ET-A receptor
38. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: Role of ET-A receptors and platelet-activating factor
39. Endothelin-1 stimulates human monocytes in vitro to release TNF-α, interleukin-β and interleukin-6
40. ET-1 induces interleukin-6 gene expression in human umbilical vein endothelial cells: Synergistic effect of interleukin-1
41. Massive amounts of immunoreactive endothelin in human seminal fluid
42. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostrate cancer
43. Frequent promoter methylation of the endothelin B receptor gene ENDRB in human renal tumors
44. Enhanced endothelin ETB receptor down-regulation in human tumor cells
45. Decreased ET(B) receptor expression in human metastatic melanoma cells
46. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma
47. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium
48. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate
49. Raised endothelin 1 levels in patients with colorectal liver metastases
50. Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: A proposed mitogen for human breast fibroblasts
51. Endothelin axis expression in renal cell carcinoma
52. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: Evidence for an autocrine role in tumor growth
53. The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density
54. Production of endothelin by canine prostatic epithelial cells and its stimulatory effects on their growth
55. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors
56. Transactivation of the epidermal growth factor in endothelin-1 induced mitogenic signaling in human ovarian carcinoma cells
57. Endothelin expression and responsiveness in human ovarian carcinoma cell lines
58. Expression and localization of endothelin- 1 and endothelin receptors in human meningiomas. Evidence for a role in tumor growth
59. Autocrine actions of endothelin- 1 as a growth factor in human ovarian carcinoma cells
60. A selective endothelin ETA antagonist, BQ-123, inhibits 1251-endothelin-1 (1251-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells
61. Paracrine regulation of ovarian cancer by endothelin
62. Endothelin-1 potentiates human smooth muscle cell growth to PDGF
63. Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraephithelial neoplasia
64. Inhibition of platelet-derived growth factor mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxa zole-4-carboxamide
65. Dual control of cell growth by somatomedins and platelet-derived growth factor
66. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1
67. Regulation of prostatic growth and function by peptide growth factors
68. Endothelin attenuates apoptosis in human smooth muscle cells
69. Endothelin-induced apoptosis of A 375 human melanoma cells
70. Nitric oxide-mediated apoptosis in murine mastocytoma
71. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2
72. N-methyl-D-aspartate-induced excessive formation of nitric oxide in CHP100 neuroblastoma cells produces death of BMEL melanoma cells in co-culture
73. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K- 1735 murine melanoma cells
74. Roles of nitric oxide in tumor growth
75. Angiogenesis in cancer, vascular, rheumatoid and other diseases
76. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
77. ETB receptors promote proliferation and migration of endothelial cells
78. Endothelin-3 mediated proliferation of wounded human umbilical vein endothelial cells
79. Proliferation and migration of endothelial cells is promoted by endothelins via activation of ET-B receptors
80. Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis
81. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion
82. Role of Endothelin-1 in neovascularization of ovarian carcinoma
83. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer
84. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo
85. 2+ from extra- and intracellular pools in osteoblastic cells
86. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae
87. Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures
88. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells
89. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: Implications for the vascular control of bone resorption
90. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin-A receptor blockade
91. Regional haemodynamic effects of endothelin-1 in rat and man: Unexpected adverse reaction
92. Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve
93. Endothelin localizes in the dorsal horn and acts on the spinal cord neurons: Possible involvement of dihydropyridine-sensitive calcium channels and substance P release
94. Endothelin-1 enhances capsaicin induced peptide release and CGMP accumulation in cultures of rat sensory neurons
95. RaeGA: Articular nociception by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: Inhibition by endothelin receptor antagonists
96. Endothelin-induced nociception in mice: Mediation by ETA and ETB receptors
97. Endothelin-1 induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: Modulation by simultaneous ET(B) receptor activation
98. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, and endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist
99. Endothelin antagonists
100. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
101. Interaction of endothelin-3 with endothelin receptor is essential for development of epidermal melanocytes and enteric neurons
102. Aortic arch malformation and ventricular septal defect in mice deficient in endothelin-1
103. Endothelin receptor antagonist, ABT-627, for prostate cancer: Initial trail results
104. A linear endothelin-1 analogue: Solution structure of ET-1 (Aib1,3,11,15,N1e7) by nuclear magnetic resonance spectroscopy and molecular modeling